East Bay cancer fighter takes on $125M in debt as it awaits FDA greenlight


The company is seeking FDA clearance of its latest technology that essentially turns tumors into their own beacons, allowing radiotherapy to zap the cancers more accurately.

Previous What UAB researchers will do with $3.7M grant toward heart hormone research
Next Indeed Brewing will debut THC-infused seltzer after Minnesota legalizes edibles